Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: Where Are We on the Hype Cycle?
- PMID: 35798444
- DOI: 10.1016/j.jacc.2022.05.009
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: Where Are We on the Hype Cycle?
Keywords: hypertrophic cardiomyopathy; medical management; novel therapeutics.
Conflict of interest statement
Funding Support and Author Disclosures The author has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.J Am Coll Cardiol. 2022 Jul 12;80(2):95-108. doi: 10.1016/j.jacc.2022.04.048. J Am Coll Cardiol. 2022. PMID: 35798455 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
